scholarly journals Normal Reference Range for Mean Tissue Glucose and Glycemic Variability Derived from Continuous Glucose Monitoring for Subjects Without Diabetes in Different Ethnic Groups

2011 ◽  
Vol 13 (9) ◽  
pp. 921-928 ◽  
Author(s):  
Nathan R. Hill ◽  
Nick S. Oliver ◽  
Pratik Choudhary ◽  
Jonathan C. Levy ◽  
Peter Hindmarsh ◽  
...  
2017 ◽  
Author(s):  
Mavin Macauley ◽  
Mohamed Shagwi ◽  
Kim Howe ◽  
Andrew Curry ◽  
Elizabeth Howell ◽  
...  

Diabetes ◽  
2020 ◽  
Vol 69 (Supplement 1) ◽  
pp. 863-P
Author(s):  
YUAN ZHANG ◽  
EVAN A. OLAWSKY ◽  
ALISON C. ALVEAR ◽  
LYNN E. EBERLY ◽  
LISA S. CHOW

2018 ◽  
Vol 14 (4) ◽  
pp. 395-403 ◽  
Author(s):  
Karem Mileo Felício ◽  
Ana Carolina Contente Braga de Souza ◽  
Joao Felicio Abrahao Neto ◽  
Franciane Trindade Cunha de Melo ◽  
Carolina Tavares Carvalho ◽  
...  

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Fumi Uemura ◽  
Yosuke Okada ◽  
Keiichi Torimoto ◽  
Yoshiya Tanaka

AbstractTime in range (TIR) is an index of glycemic control obtained from continuous glucose monitoring (CGM). The aim was to compare the glycemic variability of treatment with sulfonylureas (SUs) in type 2 diabetes mellitus (T2DM) with well-controlled glucose level (TIR > 70%). The study subjects were 123 patients selected T2DM who underwent CGM more than 24 h on admission without changing treatment. The primary endpoint was the difference in glycemic variability, while the secondary endpoint was the difference in time below range < 54 mg/dL; TBR < 54, between the SU (n = 63) and non-SU (n = 60) groups. The standard deviation, percentage coefficient of variation (%CV), and maximum glucose level were higher in the SU group than in the non-SU group, and TBR < 54 was longer in the high-dose SU patients. SU treatment was identified as a significant factor that affected %CV (β: 2.678, p = 0.034). High-dose SU use contributed to prolonged TBR < 54 (β: 0.487, p = 0.028). Our study identified enlarged glycemic variability in sulfonylurea-treated well-controlled T2DM patients and high-dose SU use was associated with TBR < 54. The results highlight the need for careful adjustment of the SU dose, irrespective of glycated hemoglobin level or TIR value.


2018 ◽  
Vol 103 (4) ◽  
pp. 1696-1703 ◽  
Author(s):  
Grethe Å Ueland ◽  
Paal Methlie ◽  
Marianne Øksnes ◽  
Hrafnkell B Thordarson ◽  
Jørn Sagen ◽  
...  

2018 ◽  
Vol 52 ◽  
pp. 224-224
Author(s):  
R.K. Pooh ◽  
T. Nakamura ◽  
M. Machida ◽  
K. Uenishi ◽  
K. Kusunoki ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document